Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Dose-Escalation Study of SCD-101 in Sickle Cell Disease
Phase 1
Active, not recruiting
- Conditions
- Sickle Cell DiseaseSickle-Beta Zero Thalassemia
- Interventions
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2023-03-21
- Lead Sponsor
- Invenux, LLC
- Target Recruit Count
- 60
- Registration Number
- NCT02380079
- Locations
- 🇺🇸
King's County Hospital, Brooklyn, New York, United States
News
No news found